// App-Quantinova.ai

e16058 : Large retroperitoneal lymphadenopathy (RPLN) and increased risk of venous thromboembolism (VTE) in patients (pts) with metastatic germ cell tumours (mGCT): A Global Germ Cell Cancer Group (G3) Study.

Researchers

Presenter

  • Ben Tran

Principal Investigators

  • Jose Manuel Ruiz Morales

  • Enrique Gonzalez-Billalabeitia

  • Eitan Amir

  • Christoph Alexander Seidel

  • Carsten Bokemeyer

  • Christian Daniel Fankhauser

  • Thomas Hermanns

  • Alexey Rumyantsev

  • Alexey Tryakin

  • Margarida Brito Goncalves

  • Aude Flechon

  • Tina Cheng

  • Daniel E. Castellano

  • Xavier Garcia del Muro

  • Daniel Yick Chin Heng

  • Phillipe Bedard

Medical Centers

  • Royal Melbourne Hospital, Melbourne, Australia

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

  • Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Department of Oncology, Haematology and Bone Marrow Transplantation with section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • University Hospital of Zurich, Zurich, Switzerland

  • Instituto Portugues De Oncologia Francisco Gentil De Lisboa, Lisbon, Portugal

  • Centre Leon Berard, Lyon, France

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Institut Catala d'Oncologia, l'Hospitalet de Llobregat, Barcelona, Spain

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

Locations

  • Canada

  • Germany

  • Spain

  • Switzerland

  • Australia

  • Portugal

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved